Erythromycin 2%/Clindamycin 1% Topical Suspension is a liquid medication with solid particles, designed for topical application. Its smooth consistency allows for uniform distribution on the skin, effectively treating conditions such as Acne Vulgaris, Folliculitis, Cellulitis, Rosacea, and Impetigo, thereby promoting improved skin health.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to offer a specially compounded topical suspension of Erythromycin 2%/Clindamycin 1%. This unique formulation is designed to address a range of skin conditions, including acne, rosacea, and bacterial skin infections. The dual-action of these two potent antibiotics works synergistically to reduce inflammation and eliminate bacteria that can lead to infection.
Erythromycin is a broad-spectrum antibiotic that functions by inhibiting bacterial growth. Clindamycin, on the other hand, is an antibiotic that not only halts bacterial growth but also reduces inflammation.
The combination of these two antibiotics in our topical suspension formulation provides a powerful tool in the fight against skin conditions. The liquid formulation, containing solid particles dispersed in a liquid medium, is specifically designed for topical application. It offers a smooth and easy-to-spread consistency.
This formulation is suitable for all skin types and is easy to apply. It is crucial to adhere to the usage instructions provided by your healthcare provider to achieve the best results. If you have any queries about this formulation or how it can assist in treating your skin condition, please do not hesitate to contact us at Bayview Pharmacy.
Erythromycin 2%/Clindamycin 1% Topical Suspension is a specially formulated liquid solution containing solid particles, designed for direct application to the skin. This unique formulation is intended to provide targeted treatment for a variety of skin conditions, including acne vulgaris and impetigo, as well as other skin infections caused by susceptible organisms.
It is crucial to understand that this formulation is not suitable for treating other skin conditions such as rosacea, eczema, or psoriasis. Furthermore, it should not be used by individuals who have a known hypersensitivity to either erythromycin or clindamycin. Patients are advised to avoid contact with the eyes, nose, and mouth while using this product. In case of accidental contact, the area should be thoroughly rinsed with water.
The Erythromycin 2%/Clindamycin 1% Topical Suspension should be applied to the affected area twice daily, or as directed by a healthcare provider. It is recommended that patients wash their hands before and after applying the product. This product should not be used for longer than 8 weeks. If symptoms persist beyond this period, patients should consult their healthcare provider.
Patients are also advised to avoid using other topical products on the same area of skin as the Erythromycin 2%/Clindamycin 1% Topical Suspension, as this may increase the risk of skin irritation. Additionally, exposure to sunlight or artificial UV light should be avoided while using this product, as it may increase the risk of sunburn.
If you have any questions or concerns about the use of Erythromycin 2%/Clindamycin 1% Topical Suspension, please do not hesitate to reach out for further information.
Erythromycin 2%/Clindamycin 1% Topical Suspension is a compounded formulation designed to treat a variety of skin conditions. This includes acne, rosacea, and bacterial infections. The combination of erythromycin and clindamycin in this formulation works synergistically to kill the bacteria causing these conditions, reducing the risk of antibiotic resistance by attacking the bacteria in different ways.
Designed as a liquid formulation with solid particles dispersed in a liquid medium, this topical suspension is specifically crafted for application to the skin. It offers a smooth and easy-to-spread consistency, ensuring a uniform distribution of the active ingredients on the skin surface.
Upon application, the suspension works by eliminating the bacteria causing the infection, while also reducing inflammation and redness. It is recommended to apply the suspension to the affected area twice daily, or as directed by a healthcare professional. It is crucial to wash your hands before and after applying the suspension to prevent further spread of bacteria.
While Erythromycin 2%/Clindamycin 1% Topical Suspension is generally well tolerated, some individuals may experience side effects such as skin irritation, dryness, or burning. If any of these side effects occur, it is advised to contact a healthcare professional for guidance.
For any further questions or concerns regarding Erythromycin 2%/Clindamycin 1% Topical Suspension, it is recommended to reach out to a healthcare provider or pharmacist. They can provide additional information and help determine the best treatment for individual skin conditions.
This is a liquid formulation containing solid particles dispersed in a liquid medium. It is specifically designed for topical application to the skin. It provides targeted treatment for various skin conditions, such as inflammation, itching, or skin irritation.
The suspension offers a smooth and easy-to-spread consistency that allows for uniform distribution of the active ingredients on the skin surface.
The active ingredients in this formulation are Erythromycin and Clindamycin. Erythromycin is present at a concentration of 2% and Clindamycin at a concentration of 1%.
This formulation can treat various skin conditions such as inflammation, itching, or skin irritation. However, it's always best to consult with a healthcare provider for specific treatment advice.
This formulation is designed for topical application. It should be applied to the affected area as directed by a healthcare provider. The smooth consistency allows for easy spreading and uniform distribution on the skin surface.
While this formulation is designed to be gentle on the skin, individuals with sensitive skin should consult with a healthcare provider before use. They can provide advice based on your specific skin type and condition.
As with any medication, there may be potential side effects. These can vary from person to person. If you experience any unusual symptoms after application, stop use and consult with a healthcare provider immediately.
It's best to consult with a healthcare provider before combining this formulation with other skincare products. They can provide advice based on the specific products you are using and your skin condition.
The time it takes to see results can vary depending on the individual and the severity of the skin condition. Consistent use as directed by a healthcare provider is key to seeing improvement.
Yes, this formulation is designed for topical application and can be used on the face. However, avoid contact with the eyes and mouth. If the product gets into these areas, rinse thoroughly with water.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)